Novartis is a multinational pharmaceutical company headquartered in Basel, Switzerland. The company specializes in the research, development, manufacturing, and marketing of a wide range of innovative pharmaceutical products, both prescription and over-the-counter drugs. With a history dating back more than 250 years, Novartis has emerged as one of the largest pharmaceutical companies globally.
Novartis is known for its extensive portfolio of medications that cover various therapeutic areas such as oncology (cancer treatment), cardiovascular diseases, neurology, ophthalmology, respiratory conditions, immunology, dermatology, and more. The company invests heavily in research and development to bring forth groundbreaking pharmaceutical solutions, contributing to advancements in medical science and patient health outcomes.
Furthermore, Novartis is actively engaged in biotechnology and gene therapies, pushing the boundaries of personalized medicine. The company collaborates with academic institutions, scientific organizations, and healthcare providers to drive innovation and advancements in patient care.
In addition to pharmaceuticals, Novartis operates in the eye care sector through its subsidiary Alcon, which focuses on creating surgical equipment, contact lenses, and eye care products.
Novartis has a global presence, with operations in numerous countries worldwide and a strong commitment to ensuring accessibility and affordability of its products to patients around the globe. The company adheres to rigorous ethical standards and regulatory compliance, aiming to deliver safe, effective, and high-quality medications to improve the health and well-being of individuals worldwide.
